Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling
- PMID: 26497513
- PMCID: PMC4621791
- DOI: 10.1111/imr.12336
Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling
Abstract
Receptors for immunoglobulin Fc regions play multiple critical roles in the immune system, mediating functions as diverse as phagocytosis, triggering degranulation of basophils and mast cells, promoting immunoglobulin class switching, and preventing excessive activation. Transmembrane signaling associated with these functions is mediated primarily by two amino acid sequence motifs, ITAMs (immunoreceptor tyrosine-based activation motifs) and ITIMs (immunoreceptor tyrosine-based inhibition motifs) that act as the receptors' interface with activating and inhibitory signaling pathways, respectively. While ITAMs mobilize activating tyrosine kinases and their consorts, ITIMs mobilize opposing tyrosine and inositol-lipid phosphatases. In this review, we will discuss our current understanding of signaling by these receptors/motifs and their sometimes blurred lines of function.
Keywords: Fc receptors; ITAMs; ITIMs; SHIP; SHP; signal transduction.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Inhibitory ITAMs as novel regulators of immunity.Immunol Rev. 2009 Nov;232(1):59-71. doi: 10.1111/j.1600-065X.2009.00832.x. Immunol Rev. 2009. PMID: 19909356 Review.
-
SPAP2, an Ig family receptor containing both ITIMs and ITAMs.Biochem Biophys Res Commun. 2002 May 10;293(3):1037-46. doi: 10.1016/S0006-291X(02)00332-7. Biochem Biophys Res Commun. 2002. PMID: 12051764
-
The inhibitory potential of Fc receptor homolog 4 on memory B cells.Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13489-94. doi: 10.1073/pnas.1935944100. Epub 2003 Nov 3. Proc Natl Acad Sci U S A. 2003. PMID: 14597715 Free PMC article.
-
Fc receptor biology.Annu Rev Immunol. 1997;15:203-34. doi: 10.1146/annurev.immunol.15.1.203. Annu Rev Immunol. 1997. PMID: 9143687 Review.
-
Fc receptor inside-out signaling and possible impact on antibody therapy.Immunol Rev. 2015 Nov;268(1):74-87. doi: 10.1111/imr.12332. Immunol Rev. 2015. PMID: 26497514 Review.
Cited by
-
Multistep IgE Mast Cell Desensitization Is a Dose- and Time-Dependent Process Partially Regulated by SHIP-1.J Immunol. 2023 Mar 15;210(6):709-720. doi: 10.4049/jimmunol.2100485. J Immunol. 2023. PMID: 36881903 Free PMC article.
-
The Complex Association of FcγRIIb With Autoimmune Susceptibility.Front Immunol. 2019 Oct 15;10:2061. doi: 10.3389/fimmu.2019.02061. eCollection 2019. Front Immunol. 2019. PMID: 31681256 Free PMC article. Review.
-
Allergen-Specific IgA Antibodies Block IgE-Mediated Activation of Mast Cells and Basophils.Front Immunol. 2022 Jul 5;13:881655. doi: 10.3389/fimmu.2022.881655. eCollection 2022. Front Immunol. 2022. PMID: 35865546 Free PMC article.
-
Molecular mechanisms of macrophage Toll-like receptor-Fc receptor synergy.F1000Res. 2018 Jan 8;7:21. doi: 10.12688/f1000research.12679.1. eCollection 2018. F1000Res. 2018. PMID: 29375818 Free PMC article. Review.
-
Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.Front Immunol. 2019 Apr 12;10:811. doi: 10.3389/fimmu.2019.00811. eCollection 2019. Front Immunol. 2019. PMID: 31057544 Free PMC article. Review.
References
-
- Paul-Eugene N, et al. Ligation of CD23 triggers cAMP generation and release of inflammatory mediators in human monocytes. J Immunol. 1992;149:3066–3071. - PubMed
-
- Kolb JP, et al. Ligation of CD23 triggers cyclic AMP generation in human B lymphocytes. J Immunol. 1993;150:4798–4809. - PubMed
-
- Chan MA, Gigliotti NM, Matangkasombut P, Gauld SB, Cambier JC, Rosenwasser LJ. CD23-mediated cell signaling in human B cells differs from signaling in cells of the monocytic lineage. Clin Immunol. 2010;137:330–336. - PubMed
-
- Ten RM, McKinstry MJ, Trushin SA, Asin S, Paya CV. The signal transduction pathway of CD23 (Fc) targets I kappa B kinase. J Immunol. 1999;163:3851–3857. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources